Home/Filings/5/0001387131-18-000678
5//SEC Filing

Glover Eddie Wabern 5

Accession 0001387131-18-000678

CIK 0000887247other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 7:04 PM ET

Size

6.2 KB

Accession

0001387131-18-000678

Insider Transaction Report

Form 5
Period: 2017-12-31
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
  • Gift

    Common Stock

    2017-02-1541,666783,334 total
  • Gift

    Common Stock

    2017-11-0241,666783,334 total

Issuer

Adamis Pharmaceuticals Corp

CIK 0000887247

Entity typeother

Related Parties

1
  • filerCIK 0001671547

Filing Metadata

Form type
5
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:04 PM ET
Size
6.2 KB